Relationships between left ventricular mass and QRS duration in diverse types of left ventricular hypertrophy

Guillaume Domain1, Cecile Chouquet2, Patricia Réant3

  • 1Department of Cardiology, University Hospital Rangueil, 1 avenue Pr. Jean Poulhès 31400 Toulouse, France.

Insights

In hypertrophic cardiomyopathy (HCM), left ventricular mass (LVM) negatively correlates with QRS duration. Conversely, QRS duration increases with LVM in left ventricular hypertrophy (LVH) and other conditions, suggesting distinct disease mechanisms.

Area of Science:

  • Cardiology
  • Cardiac Electrophysiology
  • Cardiovascular Imaging

Background:

  • Hypertrophic cardiomyopathy (HCM) may present with narrow QRS durations.
  • Left ventricular hypertrophy (LVH) can be associated with prolonged QRS duration.
  • Understanding the relationship between QRS duration and left ventricular mass (LVM) is crucial for diagnosing cardiac conditions.

Purpose of the Study:

  • To investigate the correlation between QRS duration and LVM in different subtypes of abnormal left ventricular wall thickness.
  • To compare these relationships in hypertrophic cardiomyopathy (HCM), left ventricular non-compaction (LVNC), left ventricular hypertrophy (LVH), and healthy controls.

Main Methods:

  • Automated measurement of LVM using cardiac MRI and QRS duration using ECG.
  • Retrospective analysis of 221 HCM, 28 LVNC, 16 LVH, and 40 control subjects.
  • Uni and multivariate analyses to identify factors influencing LVM and QRS duration, and subgroup analysis of their relationship.

Main Results:

  • Significant differences in mean QRS duration and LVM were observed across groups (P < 0.01).
  • QRS duration, LVM, hypertension, maximal wall thickness, and late gadolinium enhancement were linked to HCM.
  • An independent negative correlation between LVM and QRS duration was found in HCM, unlike the positive correlation in LVNC, LVH, and controls.

Conclusions:

  • The relationship between QRS duration and LVM differs significantly between HCM and conditions like LVH or healthy hearts.
  • A reverse relationship exists in HCM, with increasing LVM associated with decreasing QRS duration.
  • These findings may aid in refining diagnostic criteria for HCM.
Abstract

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
121
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
145
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
124
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
70
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
157
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
160